<DOC>
	<DOCNO>NCT03066518</DOCNO>
	<brief_summary>Introduction : Patients dementia may suffer poor sleep quality . Disturbance metabolism melatonin may role pathogenesis sleep-wake cycle alteration dementia . Objective : To evaluate efficacy low dose exogenous melatonin improve sleep quality . Design : A single-center randomized , double-blinded , placebo-controlled study carry outpatient dementia sleep alteration . Participants : The investigator calculate 40 individual age 65 year diagnosis mild-moderate dementia ( Clinical Dementia Rating 1-2 ) . Intervention : Patients randomize receive either 5 mg melatonin placebo every night 8 week . Measurements : The primary outcome sleep quality accord Pittsburgh Sleep Quality Index ( PSQI ) .</brief_summary>
	<brief_title>Effect Melatonin Sleep Quality Patients Dementia</brief_title>
	<detailed_description>This single-center study . The study protocol , informed consent , amendment approve write appropriate local site Independent Ethics Committee ( IEC ) /Institutional Review Boards ( IRB ) ( Ethics Committee Universidad Autónoma de Nuevo León , School Medicine ) . The patient recruit outpatient Geriatrics Clinic . A total 67 patient screen 40 male female patient diagnose mild moderate dementia recruit study . Following inclusion , patient underwent randomization treatment melatonin ( 5 mg orally ) placebo 8 week . To prevent bias , match placebo tablet , identical appearance , taste , odor , use . The treatment double-blinded , two parallel treatment group . Selection treatment group determine computer-generated randomization list , 1:1 ratio use randomize permuted block method .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Older 60 year ; Circadian cycle sleep disorder insomnia ( accord Diagnostic Statistical Manual Mental Disorders V criterion ) ; Mild moderate dementia ( clinical dementia rating 1 2 ) ; Medications antidepressant , acetylcholinesterase inhibitor , antipsychotic memantine allow long initiated 8 week . They diagnose sleep disorder , know hypersensitivity melatonin , use stimulant hypnotic , recent diagnosis ( within 8 week ) mood disorder neuropsychiatric symptom .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>melatonin</keyword>
	<keyword>sleep</keyword>
	<keyword>dementia</keyword>
	<keyword>cognition</keyword>
</DOC>